Predicting risk of adverse drug reactions in older adults
Reads0
Chats0
TLDR
Good clinical practice for detecting and predicting ADRs in vulnerable patients includes detailed documentation and regular review of prescribed and over-the-counter medications through standardized medication reconciliation.Abstract:
Adverse drug reactions (ADRs) are common in older adults, with falls, orthostatic hypotension, delirium, renal failure, gastrointestinal and intracranial bleeding being amongst the most common clinical manifestations. ADR risk increases with age-related changes in pharmacokinetics and pharmacodynamics, increasing burden of comorbidity, polypharmacy, inappropriate prescribing and suboptimal monitoring of drugs. ADRs are a preventable cause of harm to patients and an unnecessary waste of healthcare resources. Several ADR risk tools exist but none has sufficient predictive value for clinical practice. Good clinical practice for detecting and predicting ADRs in vulnerable patients includes detailed documentation and regular review of prescribed and over-the-counter medications through standardized medication reconciliation. New medications should be prescribed cautiously with clear therapeutic goals and recognition of the impact a drug can have on multiple organ systems. Prescribers should regularly review medication efficacy and be vigilant for ADRs and their contributory risk factors. Deprescribing should occur at an individual level when drugs are no longer efficacious or beneficial or when safer alternatives exist. Inappropriate prescribing and unnecessary polypharmacy should be minimized. Comprehensive geriatric assessment and the use of explicit prescribing criteria can be useful in this regard.read more
Citations
More filters
Journal ArticleDOI
Prevalence and Associated Factors of Drug-Related Problems Among Older People: A Cross-Sectional Study at King Chulalongkorn Memorial Hospital in Bangkok
TL;DR: The prevalence of drug-related problems in urban-living older people at King Chulalongkorn Memorial Hospital in Bangkok was high and polypharmacy and multiple comorbidities were significantly related to drug- related problems.
Journal ArticleDOI
The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy
TL;DR: The program offers a complex view regarding the ADR profile of a given patient and could be used by the physician and clinical pharmacist during patient safety monitoring, for a coherent therapy choice or medication adjustment, due to the good therapy coverage and the inclusion of relevant patient comorbidities.
Journal ArticleDOI
Implementation of Proton Pump Inhibitor Deprescription Protocol in Geriatric Residents.
Ovadyah Avraham,Michael Biglow +1 more
TL;DR: The present pilot study added to the growing body of evidence that gradual deprescription of antisecretory medications is feasible and potentially minimize overuse of proton pump inhibitors in a safe, effective, and feasible manner in the nursing home.
Journal ArticleDOI
Molecularly imprinted polymer-modified carbon paste electrodes (MIP-CPE): A review on sensitive electrochemical sensors for pharmaceutical determinations
Hanif Afsharara,Elham Asadian,Bahar Mostafiz,Kamran Banan,Sara Bigdeli,Dara Hatamabadi,A Keshavarz,Chaudhery Mustansar Hussain,Rüstem Keçili,F. Ghorbani-Bidkorpeh +9 more
TL;DR: In this article , the authors present a categorized report on the recent research and the outcomes in the combinatory fields of molecular imprinted polymers and carbon paste electrodes for determining pharmaceuticals in complex and simple matrices.
Journal ArticleDOI
Advances in pain management for older patients with cancer.
Georges El Hachem,Francisco De Assis Oliveira Rocha,Thierry Pepersack,Youssef Jounblat,Annie Drowart,Lissandra Dal Lago +5 more
TL;DR: An overview of the challenges present in assessment and treatment choices are provided, along with practical tips for routine clinical practice and barriers to the effective and safe management of analgesics are reviewed.
References
More filters
Journal ArticleDOI
A method for estimating the probability of adverse drug reactions
Claudio A. Naranjo,Usoa E. Busto,Edward M. Sellers,Paul Sandor,I Ruiz,E A Roberts,E Janecek,Domecq C,David J. Greenblatt +8 more
TL;DR: It was shown that the ADR probability scale has consensual, content, and concurrent validity and may be applicable to postmarketing drug surveillance.
Journal ArticleDOI
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
TL;DR: The incidence of serious and fatal adverse drug reactions in US hospitals was found to be extremely high, and data suggest that ADRs represent an important clinical issue.
Journal ArticleDOI
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Munir Pirmohamed,Sally James,Shaun Meakin,Chris D. Green,A Scott,Tom Walley,Keith Farrar,B. Kevin Park,Alasdair Breckenridge +8 more
TL;DR: The burden ofADRs on the NHS is high, accounting for considerable morbidity, mortality, and extra costs, and measures need to be put into place to reduce the burden of ADRs and thereby further improve the benefit:harm ratio of the drugs.
Journal ArticleDOI
Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.
Donna M. Fick,James W. Cooper,William E. Wade,Jennifer L. Waller,J. Ross Maclean,Mark H. Beers +5 more
TL;DR: The application of the Beers criteria and other tools for identifying potentially inappropriate medication use will continue to enable providers to plan interventions for decreasing both drug-related costs and overall costs and thus minimize drug- related problems.
Journal ArticleDOI
Adverse drug reactions: definitions, diagnosis, and management.
TL;DR: An adverse drug reaction is an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product.